{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:00:18Z","timestamp":1770217218148,"version":"3.49.0"},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":3913,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1995,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prophylactic intravesical chemotherapy (IVC) reduces recurrence rates of superficial transitional cell carcinoma (TCC) of the urinary bladder. The patient cohort existed of 86 individuals (stage TaNOMO or T1N0M0) superficial carcinoma of various grades of malignancy. Following initial transuretheral resection or diagnostic cystoscopy, mitomycin C (MMC), 20 mg dissolved in 50 ml saline, was instilled intravesically by catheter over 1 hr at 2\u2010week intervals, initially and then four more times followed by diagnostic cystoscopy (one course = 12 weeks). Two similar courses were administered thereafter for a total period of 36 weeks. For patients in remission, installations continued in monthly fractionations for 9 more months (cystoscopy every 3 months) and then at 2\u2010month intervals for 12 more months (cystoscopy every 6 months). When cystoscopy revealed recurrence, IVC was repeated from the beginning. No symptoms of MMC\u2010related toxicity were observed. Cystoscopic follow\u2010up evaluations showed a complete response rate of 84% at 3 years and 81 % at 5 years after initial therapy. Twenty\u2010seven patients who had not responded to previous treatment with other drugs responded to MMC. \u00a9 1995 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jso.2930600310","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T13:51:46Z","timestamp":1171979506000},"page":"191-195","source":"Crossref","is-referenced-by-count":2,"title":["Long\u2010term follow\u2010up of patients with superficial transitional cell carcinoma of the urinary bladder treated by intravesical mitomycin C"],"prefix":"10.1002","volume":"60","author":[{"given":"Abraham","family":"Pavlotsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Eidelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida","family":"Barak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalio","family":"Walach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"598","article-title":"The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette\u2010Gu\u00e9rin","volume":"133","author":"DeKemion JB","year":"1985","journal-title":"JUrol"},{"key":"e_1_2_1_3_2","volume-title":"International Perspectives in Urology: Bladder Cancer","author":"O'Connell KJ","year":"1984"},{"key":"e_1_2_1_4_2","first-page":"215","article-title":"Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma","volume":"310","author":"Soloway MS","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0094-0143(21)00346-3","article-title":"Transurethral resection and intravesical therapy of superficial bladder tumors","volume":"18","author":"Herr HW","year":"1991","journal-title":"Urol Clin North Am"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55151-4"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930280414"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(91)80119-R"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930410106"},{"key":"e_1_2_1_10_2","first-page":"315","volume-title":"Medical Oncology","author":"Stimler C","year":"1993"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45923-4"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53725-8"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"fS67\u201071","DOI":"10.1007\/BF00262490","article-title":"Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview","volume":"20","author":"Denis L","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930270115"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55018-1"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)62408-X"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1983.tb03402.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1025::AID-CNCR2820530502>3.0.CO;2-D"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)50963-5"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000472937","article-title":"Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors","volume":"14","author":"Huland H","year":"1988","journal-title":"Eur Urol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39368-0"},{"key":"e_1_2_1_22_2","first-page":"26","article-title":"Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: Short\u2010term courses or maintenance therapy","volume":"31","author":"van der Meijden AP","year":"1988","journal-title":"Urology"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40882-2"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930600310","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930600310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T15:49:14Z","timestamp":1698335354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930600310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["10.1002\/jso.2930600310"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930600310","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}